Photo by omarprestwich from unsplash
Recently receiving Food and Drug Administration approval, the Amplatzer Amulet™ left atrial appendage occluder device (Abbott Medical Inc.) provides a dual seal mechanism alternative to the commercially available Watchman FLX… Click to show full abstract
Recently receiving Food and Drug Administration approval, the Amplatzer Amulet™ left atrial appendage occluder device (Abbott Medical Inc.) provides a dual seal mechanism alternative to the commercially available Watchman FLX or Watchman 2.5 device for embolic stroke prevention in patients with nonvalvular atrial fibrillation. This step‐by‐step review will cover patient selection, preprocedure imaging assessment, device sizing, device preparation, implant target position assessment, implant technique and troubleshooting, and immediate postimplant follow‐up.
Journal Title: Journal of Cardiovascular Electrophysiology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!